Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682039 · ClinicalTrials.gov registry record · NA
Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors
A NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06682039: Completed NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm, sponsored by Fred Hutchinson Cancer Center.
NCT06682039 is a NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06682039, a NA study of Childhood Malignant Solid Neoplasm and Childhood Hematopoietic and Lymphatic System Neoplasm, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negative outcomes such as poor quality of life, depression, distress, substance use, sleep problems, fatigue, and pain. ABM uses techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. ABM uses brief self-guided smartphone applications. Patients complete repetitive association reaction-time tasks targeting automatic and unconscious negative attention biases to retrain attention away from perceived threat and towards a neutral or positive stimuli. Gratitude-finding and savoring activities are also provided to maintain and increase positive emotions. Using ABM plus gratitude-finding and savoring activities may improve anxiety in AYA cancer survivors.
Primary Outcome
Feasibility will be assessed via clinic recruitment rates, defined as (number \[#\] of adolescent and young adults \[AYAs\] who enroll in the study) / (total # of AYAs screened as eligible). Attention bias modification (ABM) will be considered feasible with ≥ 50% enrollment.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
- OTHER Internet-Based Intervention
- OTHER Text Message-Based Navigation Intervention
Study Locations (1)
Washington
- Fred Hutch/University of Washington/Seattle Children's Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2024-11-08 |
| Est. Completion | 2026-01-12 |
| Phase | NA |
What the finished NCT06682039 record still lists
NCT06682039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Childhood Malignant Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT06682039 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT06682039 about?
NCT06682039 is a clinical study titled "Attention Bias Modification for the Improvement of Anxiety in Adolescent and Young Adult Cancer Survivors". This clinical trial studies how well attention bias modification (ABM) improves anxiety in adolescent and young adult (AYA) cancer survivors. Cancer-related anxiety is the most prevalent mental health problem affecting AYA cancer survivors. Cancer-related anxiety is associated with long-term negativ...
What is the current status of trial NCT06682039?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2024-11-08. Estimated completion is 2026-01-12.
What conditions does trial NCT06682039 study?
This clinical trial studies the following conditions: Childhood Malignant Solid Neoplasm, Childhood Hematopoietic and Lymphatic System Neoplasm.
What interventions are being tested in trial NCT06682039?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER), Internet-Based Intervention (OTHER), Text Message-Based Navigation Intervention (OTHER).
Who is sponsoring clinical trial NCT06682039?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06682039 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Malignant Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06682039's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI